Carl Goldfischer, Director at CymaBay Therapeutics, Inc. (CBAY), sold 46,729 shares at $2.76 ($128K) on 2015-09-11, disclosed to the SEC on 2015-09-11.
Open-market sale of $128k CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.76 | 905 | $2K | 1.9% |
| 2 | $2.76 | 13 | $36 | 0.0% |
| 3 | $2.76 | 13,844 | $38K | 29.8% |
| 4 | $2.71 | 1,011 | $3K | 2.1% |
| 5 | $2.71 | 15 | $41 | 0.0% |
| 6 | $2.71 | 15,474 |
| $42K |
| 32.7% |
| 7 | $2.76 | 948 | $3K | 2.0% |
| 8 | $2.76 | 14,506 | $40K | 31.2% |
| 9 | $2.77 | 13 | $36 | 0.0% |
| Total | $2.74 avg | 46,729 | $128K | 100% |
| Filing → |
| CBAY | SELL | 2018-03-23 | $195K | — | Filing → |
| CBAY | SELL | 2017-11-06 | $156K | — | Filing → |
| ETRM | SELL | 2017-05-31 | $23K | — | Filing → |